Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023-11 · 43 (11) · 1194-1205
DOI: 10.1002/phar.2858 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023-08. Verfasst von Salmaan Kanji und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Anti-Infective Agents, Sepsis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
Critically ill patients with sepsis admitted to the intensive care unit (ICU) often present with or develop renal dysfunction requiring renal replacement therapy (RRT) in addition to antimicrobial therapy. While early and appropriate antimicrobials for sepsis have been associated with an increased probability of survival, adequate dosing is also required in these patients. Adequate dosing of antimicrobials refers to dosing strategies that achieve serum drug levels at the site of infection that are able to provide a microbiological and/or clinical response while avoiding toxicity from excessive antibiotic exposure. Therapeutic drug monitoring (TDM) is the recommended strategy to achieve this goal, however, TDM is not routinely available in all ICUs and for all antimicrobials. In the absence of TDM, clinicians are therefore required to make dosing decisions based on the clinical condition of the patient, the causative organism, the characteristics of RRT, and an understanding of the physicochemical properties of the antimicrobial. Pharmacokinetics (PK) of antimicrobials can be highly variable between critically ill patients and also within the same patient over the course of their ICU stay. The initiation of RRT, which can be in the form of intermittent hemodialysis, continuous, or prolonged intermittent therapy, further complicates the predictability of drug disposition. This variability highlights the need for individualized dosing. This review highlights the practical considerations for the clinician for antimicrobial dosing in critically ill patients receiving RRT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Department of Anaesthesiology and Intensive Care, Pain and Emergency Medicine, Nîmes University Hospital, Nîmes, France.
- UR UM 103 IMAGINE, Faculty of Medicine, University of Montpellier, Nîmes, France.
- Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.
ORCID-Profile: Salmaan Kanji
Zitieren
APA
Kanji, S., Roger, C., Taccone, F. S., & Muller, L. (2023). Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(11), 1194-1205. https://doi.org/10.1002/phar.2858
Vancouver
Kanji S, Roger C, Taccone FS, Muller L. Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023;43(11):1194-1205. doi:10.1002/phar.2858
BibTeX
@article{Kanji2023,
author = {Kanji, Salmaan and Roger, Claire and Taccone, Fabio Silvio and Muller, Laurent},
title = {Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapy},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2023},
volume = {43},
number = {11},
pages = {1194--1205},
doi = {10.1002/phar.2858}
}
EUVIMED